Cotinine is the major metabolite of nicotine. It has some biological activi
ty, but its pathophysiological effects are largely unclear. We studied whet
her cotinine initiates calcium transients or affects those induced by nicot
ine. In bovine adrenal chromaffm cells labeled with the fluorescent calcium
indicator Fura 2, cotinine (0.32-3.2 mM) concentration-dependently increas
ed the intracellular Ca2+ concentration ([Ca2+](i)). The effect was abolish
ed by omitting extracellular Ca2+ during the stimulations. Also nicotinic r
eceptor channel blockers hexamethonium (10 mu M-1 mM) and chlorisondamine (
100 mu M), as well as a competitive nicotinic receptor antagonist dihydro-b
eta-erythroidine (10-100 mu M), inhibited the response. Cotinine (0.32-3.2
mM) preincubation for 2 min inhibited both the nicotine-induced and the cot
inine-induced increases in [Ca2+](i). Also nicotine (3.2-10 mu M) inhibited
the cotinine-induced increase in [Ca2+](i). Tetrodotoxin (1 mu M) and thap
sigargin (1 mu M) pretreatments did not affect the responses to cotinine, w
hile 300 nM nimodipine partially inhibited the cotinine-induced increase in
[Ca2+](i). The results indicate that cotinine has nicotine-like effects on
chromaffin cells. It may also desensitize the nicotinic cholinergic recept
ors, possibly by acting as a low-affinity agonist at these receptors, (C) 2
000 Academic Press.